While analysis of heterogeneity, or “Ki-67 hot spot” analysis, should be pursued, this is a complex problem that will require the development of a “hot-spot” definition that can be shown to drive outcome more effectively than an analysis of all the tumor cells in the section. The gene discussed is MKI67; the disease is neoplasm.